Harrison Gunn

ID: 1b83cf65-2619-30fb-68c4

/

Unclaimed

/

Organization: Goodwin Procter

Meiji Announces Promising Phase I Results for Ustekinumab Biosimilar and Initiation of Phase III Clinical Trial

Big Molecule Watch · May 26, 2021

International Biosimilar Launches: Ujvira and PrInclunox®

Big Molecule Watch · May 26, 2021

Formycon and Biocon Biologics/Viatris Share Recent Biosimilars Development News

Big Molecule Watch · March 8, 2021

Minnesota Bill Aimed at Expanding Access to Biosimilars

Big Molecule Watch · March 4, 2021

Samsung Bioepis Initiates Phase 1 Trial of Ustekinumab Biosimilar

Big Molecule Watch · March 2, 2021